CSF1 and arthritic joint disease: As reported, the in vivo administration of CSF-1 exacerbated the inflammation and joint erosion in collagen-induced arthritis (61, 62) due to the role of CSF-1 in the pathology of osteoclastogenesis and subsequent osteolysis.